White House Announces Plan to Lower Prescription Drug Costs

Biden-⁠Harris Administration announces new actions to lower prescription drug costs by promoting industry competition. With plans for a proposed framework for agencies on the exercise of march-in rights, which specify that price can be a factor for determining whether a taxpayer-funded drug or other invention is accessible to the public or not.

READ FULL ARTICLE